Criscuolo D - Search Results

1

Interferon alpha-2a and vinblastine in the treatment of metastatic renal carcinoma.

Rizzo M, Bartoletti R, Selli C, Sicignano A, Criscuolo D. Rizzo M, et al. Among authors: criscuolo d. Eur Urol. 1989;16(4):271-7. doi: 10.1159/000471590. Eur Urol. 1989. PMID: 2670581 Review.

2

Interferon alfa 2a in superficial bladder cancer prophylaxis: toleration and long-term follow-up. A phase I-II study.

Bartoletti R, Massimini G, Criscuolo D, Rizzo M. Bartoletti R, et al. Among authors: criscuolo d. Anticancer Res. 1991 Nov-Dec;11(6):2167-70. Anticancer Res. 1991. PMID: 1776857 Clinical Trial.

3

Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B.

Fattovich G, Brollo L, Boscaro S, Pontisso P, Giustina G, Criscuolo D, Maladorno D, Alberti A, Realdi G, Ruol A. Fattovich G, et al. Among authors: criscuolo d. J Hepatol. 1989 Nov;9(3):331-7. doi: 10.1016/0168-8278(89)90142-6. J Hepatol. 1989. PMID: 2691568 Clinical Trial.

4

Effects of interferon alpha-2a on catecholamines and lymphocyte beta 2 adrenoceptors in healthy humans.

Vergassola C, Pende A, Musso NR, Ioverno A, Lotti G, Criscuolo D. Vergassola C, et al. Among authors: criscuolo d. Int J Neurosci. 1990 Apr;51(3-4):211-3. doi: 10.3109/00207459008999698. Int J Neurosci. 1990. PMID: 2177736 No abstract available.

5

Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.

Realdi G, Fattovich G, Pastore G, Caredda F, Noventa F, Santantonio T, Moroni M, Criscuolo D, Maladorno D, Rugge M, et al. Realdi G, et al. Among authors: criscuolo d. J Hepatol. 1990;11 Suppl 1:S129-32. doi: 10.1016/0168-8278(90)90179-u. J Hepatol. 1990. PMID: 2079570 Clinical Trial.

6

Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides.

Simoni R, Cavalieri R, Coppola G, Ricciotti L, De Pità O, Criscuolo D, Covelli A, Papa G, Mandelli F. Simoni R, et al. Among authors: criscuolo d. J Biol Regul Homeost Agents. 1987 Apr-Jun;1(2):93-9. J Biol Regul Homeost Agents. 1987. PMID: 3504088

7

Treatment of chronic hepatitis D with interferon alfa-2a.

Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, Gibo Y, Caruso L, Scaccabarozzi S, Criscuolo D, et al. Farci P, et al. Among authors: criscuolo d. N Engl J Med. 1994 Jan 13;330(2):88-94. doi: 10.1056/NEJM199401133300202. N Engl J Med. 1994. PMID: 8259188 Free article. Clinical Trial.

8

Recombinant alpha-2a interferon (alpha-IFN) in the treatment of essential thrombocythaemia. Preliminary report.

Gugliotta L, Macchi S, Catani L, Chetti L, Mattioli Belmonte M, Guarini A, Criscuolo D, Tura S. Gugliotta L, et al. Among authors: criscuolo d. Haematologica. 1987 May-Jun;72(3):277-9. Haematologica. 1987. PMID: 3114099 No abstract available.

9

Neuroendocrine effects of interferon alpha 2-a in healthy human subjects.

Pende A, Musso NR, Vergassola C, Puppo F, Ioverno A, Criscuolo D, Indiveri F, Lotti G. Pende A, et al. Among authors: criscuolo d. J Biol Regul Homeost Agents. 1990 Apr-Jun;4(2):67-72. J Biol Regul Homeost Agents. 1990. PMID: 2175540

10

Treatment of chronic type B hepatitis, positive for the antibody to hepatitis B "e" antigen with alpha-2A-interferon.

Brunetto MR, Criscuolo D, Actis CG, Baldi M, Maran E, Capalbo M, Verme G, Bonino F. Brunetto MR, et al. Among authors: criscuolo d. Ann Med Interne (Paris). 1988;139(2):130-1. Ann Med Interne (Paris). 1988. PMID: 3395057 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters